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ABSTRACT Schnitzler syndrome (SS) is a rare autoinflammatory disease that 
presents with chronic urticaria and monoclonal immunoglobulin (Ig) M or G, 
accompanied by fever, abnormal bone remodeling, skin biopsy with a neutro-
philic dermal infiltrate, leukocytosis, or elevated C-reactive protein. It is usually 
refractory to antihistamines and immunosuppression. We present a case report 
of clinical SS without monoclonal Ig with robust response to interleukin-1 in-
hibitor anakinra. This suggests the possible existence of an incomplete form of 
SS and underlines the risk of false negative diagnosis in individuals with such 
“incomplete SS”.
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INTRODUCTION
Schnitzler Syndrome (SS) is a rare autoinflamma-
tory disease defined by the Strasbourg criteria (1,2). 
According to the definition, chronic urticarial rash 
and monoclonal immunoglobulin (Ig) M or IgG are 
obligatory in combination with two of the follow-
ing minor criteria: recurrent fever, objective findings 
of abnormal bone remodeling with or without bone 
pain, skin biopsy with a neutrophilic dermal infiltrate, 
and leukocytosis and/or elevated C-reactive protein 
(CRP) (1). Mean age of onset is 51 years, and the litera-
ture describes around 300 cases (1,2). Symptoms are 
generally refractory to antihistamine, azathioprine, 
methotrexate, tumor necrosis factor inhibitors, and 
rituximab (1,2). However, the interleukin-1 inhibitor 
anakinra quickly alleviates the symptoms and most 
likely decreases the risk of future amyloidosis, but not 
Waldenström macroglobulinemia, a lymphoprolifera-
tive complication (3). Discontinued anakinra usually 
lead to a rapid recurrence the symptoms (2). There 
are reports of patients with clinical SS without mono-
clonal gammopathy at the time of diagnosis (4), as 
well as cases of delayed monoclonal gammopathy 
development, years after onset of symptoms (3). 
CASE REPORT
A 51-year-old healthy man was referred to the 
dermatology department in 2016 after eight months 
of recurrent urticaria, fever, night sweats, joint and 
muscle pain, and minor weight loss (Figure 1). No 
one in his family had had similar symptoms. Labora-
tory testing indicated a normocytic, normochromic 
anemia with hemoglobin 129 g/L, elevated CRP 46 
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mg/L, leukocytosis 6.7×109/L, and thrombocytosis 
512×109/L. Liver, renal, and rheumatological screen-
ing including anti-double stranded deoxyribonucleic 
acid antibodies, anti-neutrophil cytoplasmic antibod-
ies, antinuclear antibodies, beta-2 microglobulin, 
complement factors, and extractable nuclear antigen 
were normal and urine and blood cultures negative. 
Electrophoresis showed kappa and lambda light 
chains of 47.2 mg/L and 28.3 mg/L, without mono-
clonal gammopathy. Histopathological examination 
revealed subepithelial edema and discrete interstitial 
and perivascular neutrophilic and eosinophilic gran-
ulocyte infiltration, indicative of urticaria, computer 
tomography (CT) showed sclerosis in the pelvic bone, 
and positron emission tomography (PET) -CT found 
increased fluorodeoxyglucose (FDG) uptake in the ax-
illary and inguinal lymph nodes. A bone marrow bi-
opsy indicated osteosclerosis, without evidence for 
malignancy. Anakinra 100 mg subcutaneously once 
daily was initiated for suspected SS, resulting in symp-
tom mitigation within days, and the hemoglobin and 
acute phase reactants normalized. The symptoms 
reoccurred quickly during treatment pauses, and 
anakinra was discontinued due to a mild headache 
and nightly pruritus, and omalizumab 300 mg every 
four weeks was subcutaneously initiated for chronic 
urticaria. A few days later, the patient developed a 
productive cough, headache, and urticaria and upon 
hospitalization the blood samples revealed CRP 250 
mg/L, leukocytosis 13.3×109/L, and hemoglobin 127 
g/L. Chest X-ray, blood cultivations, and urine analy-
sis were normal. Despite intravenous benzylpenicillin 
1.2 million units four times daily and oral cetirizine 
ten mg daily, the symptoms were only reduced once 
he received prednisolone 50 mg daily. Shortly after 
anakinra was reinstated in the same dose as before, 
omalizumab was discontinued, and at clinical control 
two and eight months later the patient only had mild 
nightly pruritus and the laboratory values had nor-
malized. 
DISCUSSION
The Strasbourg criteria’s sensitivity and specific-
ity are 81% and 100%, respectively (1). This particular 
case underlines the risk of a false negative diagnosis 
when SS manifests without monoclonal gammopa-
thy and also emphasizes the responsiveness of such 
“incomplete SS” to standard therapy. The laboratory 
findings, including anemia, elevated CRP, leukocyto-
sis, and thrombocytosis reflect an increased inflam-
matory activity that together with bone marrow os-
teosclerosis and bone sclerosis are characteristics of 
SS (2,3). Increased FDG uptake and hence metabolic 
activity in the axillar and inguinal lymph nodules, 
described in the PET-CT, is attributed to dermal in-
flammation. Schnitzler syndrome has many clinical 
features in common with autoinflammatory cryo-
pyrin-associated periodic syndrome (CAPS) (5). How-
ever, age of onset for CAPS is during childhood, and 
family members are often affected. Moreover, genetic 
testing for NLRP3 mutation can sometimes distin-
guish the two diseases. Other important differential 
diagnoses include chronic spontaneous and induc-
ible urticaria, which are limited to the skin and usu-
ally have normal serum markers (5). Histological neu-
trophilic granulocyte infiltration is a hallmark of both 
SS and adult-onset Still’s disease (5). They also share 
some laboratory findings, including leukocytosis and 
elevated erythrocyte sedimentation rate. However, 
several clinical features distinguish them from each 
other. Another serious differential diagnosis and po-
tential complication is Waldenström macroglobulin-
emia that can be excluded with bone marrow biopsy 
(5). Finally, the current absence of a monoclonal gam-
mopathy does not preclude future development of 
this diagnostic hallmark.
CONCLUSION
Physicians should consider “incomplete SS” de-
spite the absence of monoclonal gammopathy if 
other autoinflammatory symptoms are present at 
Figure 1. Hives on the patient’s back.
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the time of diagnosis (6). Early disease recognition 
allows for appropriate therapeutic intervention and 
prompt symptom control and potentially improved 
long-term prognosis for the affected patient. At the 
end of May 2020, blood samples revealed that the pa-
tient had developed monoclonal IgM of 1.4 gram/L, 
confirming the diagnosis SS, almost four years after 
onset of symptoms.
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